Heart failure drug approved by EUMorpeth HeraldSeveral other newspapers have reported on the drug ivabradine, known by the brand name Procoralan, as European drug regulators have today approved it for the treatment of chronic heart failure. In heart fa…
This is Hull and East RidingHeart failure fears for McKenzie Kimpton as he refuses to take his medicineThis is Hull and East RidingTests have showed McKenzie's pulse is too high, putting him at extreme risk of heart failure. Emma said: "His he…
New drug improves prognosis in advanced breast cancer casesLong Beach Press-TelegramThe drug everolimus (brand name Afinitor, from drug manufacturer Novartis) has been approved as a treatment for postmenopausal women with advanced hormone receptor-posi…
Zee NewsMapping 300 years of Indian landscape art with 385 art worksZee NewsNew Delhi: Three hundred years ago, India went to Europe with realistic paintings of villages, the green countryside, temples, forts, people and festivals in water colours and …
New drug improves prognosis in advanced breast cancer casesLos Angeles Daily NewsThe drug everolimus (brand name Afinitor, from drug manufacturer Novartis) has been approved as a treatment for postmenopausal women with advanced hormone receptor-positiv…
JSPL organises blood donation campSteelGuruJindal Steel and Power Limited organised a one day blood donation cum awareness camp at 19 Battalion NCC camp to mark 82nd birth anniversary of its founder OP Jindal. More than 60 persons that included NCC cad…
Organ donation campaign beginsNational Indigenous TimesThe Aboriginal and Torres Strait Islander community now has a culturally appropriate brochure at its fingertips on organ and tissue donation, featuring Aboriginal artwork. Launched by DonateLife NS…
Senior Consult: Autopsy known as 'final diagnosis'Florida TodaySome people are surprised that we don't list cardiac arrest or brain death as the immediate cause of death. Those terms describe the process of dying, but do not give the cause …
Cardionovum to introduce PROLIMUS Biograde system in EuropeNews-Medical.netCardionovum GmbH announced today that it expects to launch in Europe in Q4 2012 a next-generation Sirolimus-eluting coronary stent system—PROLIMUS Biograde—which is designed…
A girl with intellectual disability who was reportedly denied a kidney transplant earlier this year because she's "mentally retarded" will be receiving a new organ after all.